Koers Guizhou Bailing Group Pharmaceutical Co., Ltd.
Aandelen
002424
CNE100000PY3
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,38 CNY | +0,31% | -2,45% | -21,33% |
Omzet 2023 * | 4,47 mld. 618 mln. 578 mln. | Omzet 2024 * | 5,43 mld. 750 mln. 701 mln. | Marktkapitalisatie | 8,84 mld. 1,22 mld. 1,14 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | 311 mln. 42,92 mln. 40,14 mln. | Nettowinst (verlies) 2024 * | 460 mln. 63,48 mln. 59,37 mln. | EV/omzet 2023 * | 1,98 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 1,63 x |
K/w-verhouding 2023 * |
29
x | K/w-verhouding 2024 * |
19,3
x | Werknemers | 6.138 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 67,64% |
1 dag | +0,31% | ||
1 week | -2,45% | ||
Lopende maand | -14,25% | ||
1 maand | -13,78% | ||
3 maanden | -18,52% | ||
6 maanden | -20,15% | ||
Lopend jaar | -21,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Min Niu
CEO | Chief Executive Officer | 54 | 25-12-07 |
Hong Xing Li
DFI | Director of Finance/CFO | 39 | 29-12-20 |
Pei Chen
BRD | Director/Board Member | 40 | 27-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wei Jiang
CHM | Chairman | 63 | 25-12-07 |
Yong Jiang
BRD | Director/Board Member | 56 | 25-12-07 |
Min Niu
CEO | Chief Executive Officer | 54 | 25-12-07 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 31 M€ | +3,50% | - | |
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 6,38 | +0,31% | 40 929 380 |
25-04-24 | 6,36 | -1,70% | 41 576 870 |
24-04-24 | 6,47 | +0,62% | 34 965 770 |
23-04-24 | 6,43 | -1,23% | 31 552 400 |
22-04-24 | 6,51 | -0,46% | 35 729 090 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,33% | 1,22 mld. | |
-15,13% | 4,49 mld. | |
-9,75% | 3,06 mld. | |
+2,14% | 3,04 mld. | |
-6,82% | 2,61 mld. | |
+47,87% | 1,81 mld. | |
+0,09% | 1,66 mld. | |
-7,89% | 1,63 mld. | |
-12,97% | 1,55 mld. | |
+33,40% | 1,41 mld. |